Quality of LifeQoLNMDNCT02895763
Quality of Life in Neuromuscular Disease
An observational study of Quality of Life and Muscular Dystrophies, run by CHU de Reims at 1 site in France.
Trial summary
A Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Quality of Life, Muscular Dystrophies
- What is being tested?
- Form administrations
- How many people
- 159 participants
- Where
- 1 siteFrance
- Study dates
- Jun 2006to Jun 2013
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: French Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form.
Who may be able to join
- Patient with neuromuscular disease
Who cannot join
- <18 yo
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Development of a New Scale of Quality of Life, Specific of Neuro Muscular Diseases and More Specifically of Steinert Disease, by the Rasch Model Methods.
A Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies. The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers MNMs. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed. The transcript provided 2424 CIF categories. The results helped to identify and quantify aspects of life that are altered by NMDs between patients. A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were thern passed by 159 patients enrolled in eight reference centers MNMs. The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire. The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRT measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system. A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. 156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties and met IRT assumptions. The IRT model calibration was then performed successfully on 315 patients. The French version of the QoL-NMD showed adequate psychometric properties and can be used in rehabilitation services. A conversion table enables easy transformation of sum scores into IRT-calibrated measures. Minimum detectable change tables help interpreting score change.
Read the detailed description
Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies.
The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers NMDs. To ensure that the performance in terms of severity would be adequate, three focus groups were formed: (1) Patients capable of walking. (2) Patients in wheelchairs. (3) Patients in wheelchairs and requiring continue ventilatory support. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed according to the framework of the International Classification of Functioning, Disability and Health (ICF).
A total of 41 patients divided into five discussion groups were interviewed. The transcript provided 2424 ICF categories. References to percentages of different categories ICF were calculated and graphed.
The results helped to identify and quantify aspects of life that are altered by MNMs between patients. This qualitative work was the first phase of the ambitious project to develop a new specific questionnaire for NMDs HRQoL.
Build a questionnaire for assessing the quality of health-related life (HRQoL) in patients with NMD using item response theory (IRT).
A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were passed by 159 patients enrolled in eight reference centers MNMs. The exploratory analysis included statistical methods derived from both the TRI and classical test theory.
The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire.
This study has allowed the development of a new HRQL questionnaire specifically designed for patients with MNM. The QoLNMD is short enough to be used in clinical practice (26 items).
The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRR measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system.
A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. Confirmatory psychometric analyses were performed on the new sample while the Items Response Theory (IRT) model calibration was performed on all patients ever recruited using the Partial Credit Model (Rasch).
156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties (internal consistency: repeatability ; scalability) and met IRT assumptions. The IRT model calibration was performed successfully on 315 patients. Minimum detectable change estimates are distribution based and should be verified by external meaningful anchors.
- Conditions
- Quality of Life, Muscular Dystrophies
- Being tested
- Form administrations
- Keywords
- QUALITY OF LIFE, NEUROMUSCULAR DISEASES
- Medical subject headings
- Muscular Dystrophies, Neuromuscular Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Form administrationsOther
| Study group | Role | What they receive |
|---|---|---|
| Neuro Muscular disease patients | French Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form. Receives: Other: Form administrations |
What is being measured
The primary outcome is the main question the study is designed to answer.
Self reported form of items measuring the Quality of Life
The Quality of Life questionnaire used is QoLNMD
Measured: 0 month
Secondary outcomes (2)
Self reported form of items measuring the Quality of Life
The Quality of Life questionnaire used is QoLNMD
Measured: 6 months
Self reported form of items measuring the Quality of Life
The Quality of Life questionnaire used is QoLNMD
Measured: 1 year
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Sep 2016 (estimated)
- Study startJun 2006
- Primary completionDec 2012
- Study completionJun 2013
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Quality of LifeStudies of the same condition, open and under way.
- More trials run by CHU de ReimsThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 159 participants (actual)
Sponsor and investigators
- Lead sponsor
- CHU de Reims
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02895763
- Sponsor's protocol ID
- 2015Ao005
- Acronym
- QoLNMD
- Status last verified
- Sep 2016
- First submitted
- 18 Aug 2016
- Last updated
- 23 Sep 2016
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 23 Sep 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development of a New Scale of Quality of Life, Specific of Neuro Muscular Diseases and More Specifically of Steinert Disease, by the Rasch Model Methods.
- ClinicalTrials.gov ID
- NCT02895763
- Acronym / sponsor ID
- QoLNMD / 2015Ao005
- Conditions
- Quality of Life, Muscular Dystrophies
- Keywords
- QUALITY OF LIFE, NEUROMUSCULAR DISEASES
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 159 participants (actual)
- Lead sponsor
- CHU de ReimsUniversity, hospital or other
- Study start
- Jun 2006
- Primary completion
- Dec 2012 (actual)
- Study completion
- Jun 2013 (actual)
- First posted
- 12 Sep 2016 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies. The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers MNMs. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed. The transcript provided 2424 CIF categories. The results helped to identify and quantify aspects of life that are altered by NMDs between patients. A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were thern passed by 159 patients enrolled in eight reference centers MNMs. The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire. The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRT measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system. A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. 156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties and met IRT assumptions. The IRT model calibration was then performed successfully on 315 patients. The French version of the QoL-NMD showed adequate psychometric properties and can be used in rehabilitation services. A conversion table enables easy transformation of sum scores into IRT-calibrated measures. Minimum detectable change tables help interpreting score change.
Detailed description
Quality work was conducted to enable the future construction of a Quality of Life Questionnaire Related to Health (HRQoL) in patients with slowly progressive neuromuscular disease (NMD) as myopathies and muscular dystrophies.
The discussion group training is an effective method to perform a thorough investigation of aspects of HRQoL potentially altered by NMD. Patients were recruited in France by 4 reference centers NMDs. To ensure that the performance in terms of severity would be adequate, three focus groups were formed: (1) Patients capable of walking. (2) Patients in wheelchairs. (3) Patients in wheelchairs and requiring continue ventilatory support. All verbal interactions between participants focus groups were recorded. A qualitative analysis of the transcript was performed according to the framework of the International Classification of Functioning, Disability and Health (ICF).
A total of 41 patients divided into five discussion groups were interviewed. The transcript provided 2424 ICF categories. References to percentages of different categories ICF were calculated and graphed.
The results helped to identify and quantify aspects of life that are altered by MNMs between patients. This qualitative work was the first phase of the ambitious project to develop a new specific questionnaire for NMDs HRQoL.
Build a questionnaire for assessing the quality of health-related life (HRQoL) in patients with NMD using item response theory (IRT).
A pool of 64 items and a validated questionnaire (the WHOQOLBREF) were passed by 159 patients enrolled in eight reference centers MNMs. The exploratory analysis included statistical methods derived from both the TRI and classical test theory.
The investigators constructed a questionnaire called QoLNMD which is composed of two general items and 24 items classified into three areas: (1) \ Impact bodily symptoms, "(2) \ Self-perception" and (3) \ Activity participation. "Each area has good psychometric properties (Cronbach's alpha> 0.77, test-retest ICC> 0.81, H Loevinger> 0.41) and met the assumptions of IRT. the comparison with the WHOQOL-BREF was used to assess similarities and differences with a generic questionnaire.
This study has allowed the development of a new HRQL questionnaire specifically designed for patients with MNM. The QoLNMD is short enough to be used in clinical practice (26 items).
The next step was to validate the QoLNMD reassessing its psychometric properties in a new patient sample and calibrate the IRR measurement system. The purpose of these new part of study was to validate the French version of the QoL-NMD on a confirmatory sample of patients and to calibrate its measurement system.
A prospective study in 8 NMD referral centers (France) was conducted. Both the QoL-NMD and a validated generic questionnaire (the WHOQOLBREF) were administered to patients. Confirmatory psychometric analyses were performed on the new sample while the Items Response Theory (IRT) model calibration was performed on all patients ever recruited using the Partial Credit Model (Rasch).
156 patients were included for the confirmatory psychometric analysis. All three domains showed adequate psychometric properties (internal consistency: repeatability ; scalability) and met IRT assumptions. The IRT model calibration was performed successfully on 315 patients. Minimum detectable change estimates are distribution based and should be verified by external meaningful anchors.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Neuro Muscular disease patients | – | Other: Form administrationsFrench Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- French Patients, young adults and adults, with a diagnosed neuromuscular disease, of any known form.
Key inclusion criteria (1 listed)
- Patient with neuromuscular disease
Key exclusion criteria (1 listed)
- <18 yo
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Form administrations | Other | Neuro Muscular disease patients |
Primary outcome
Self reported form of items measuring the Quality of Life
Time frame: 0 month
The Quality of Life questionnaire used is QoLNMD
2 secondary outcomes
Self reported form of items measuring the Quality of Life
Time frame: 6 months
Self reported form of items measuring the Quality of Life
Time frame: 1 year
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Sep 2016.
Related trials for Quality of Life
RecruitingObservational study
Endoscopic Sleeve Gastroplasty (ESG) Prospective Trial for Obesity (EGO-Trial)
Obesity
RecruitingPhase 4
The Effects of Ferric Derisomaltose in Patients With Acute Heart Failure and Iron Deficiency on Exercise Capacity and Quality of Life(COREVIVE-HFrEF)
Heart Failure With Reduced Ejection Fraction, Iron Deficiency
Recruiting
Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors
Cancer, Survivorship
Not yet recruitingObservational study
Functional Impact of Psychological Symptoms in Patients With Superior Semicircular Canal Dehiscence Syndrome (SSCD): a National Cross-sectional Study
Superior Semicircular Canal Dehiscence
Not yet recruitingPhase 2
Alberta Cancer Exercise Dose in Colorectal Cancer
Cancer, Colorectal Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Quality of Life and Muscular Dystrophies, run by CHU de Reims at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Self reported form of items measuring the Quality of Life (time frame: 0 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Sep 2016.